{"id":"https://openalex.org/W7225155113","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","title":"317 Advancing allogeneic CARMAIT cell therapy: isolation, expansion, and engineering for cancer and immune disorders","display_name":"317 Advancing allogeneic CARMAIT cell therapy: isolation, expansion, and engineering for cancer and immune disorders","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225155113","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0317"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0317","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A359.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A359.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065904019","display_name":"Dexian Quan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dexian Quan","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041126345","display_name":"Yuhua Wan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuhua Wan","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160496188","display_name":"Qi Ding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Ding","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160495498","display_name":"Youwen Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Youwen Su","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160534876","display_name":"Meng Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meng Huang","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160500611","display_name":"Sicheng Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sicheng Lin","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057546748","display_name":"Jian Hua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jian Hua","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160440919","display_name":"Jingyu Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingyu Li","raw_affiliation_strings":["SPH Biotherapeutics (Shanghai), Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (Shanghai), Shanghai, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160408456","display_name":"Hua Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hua Zhang","raw_affiliation_strings":["SPH Biotherapeutics (HK), Limited, Hong Kong, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SPH Biotherapeutics (HK), Limited, Hong Kong, Hong Kong","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A359","last_page":"A359"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mucosa-associated-invariant-t-cells","display_name":"mucosal-associated invariant T cells","score":0.953000009059906},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.5479999780654907},{"id":"https://openalex.org/keywords/anti-cd19-car","display_name":"anti-CD19 CAR","score":0.8389999866485596},{"id":"https://openalex.org/keywords/off-the-shelf-cell-therapy","display_name":"off-the-shelf cell therapy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/innate-like-t-cells","display_name":"innate-like T cells","score":0.6299999952316284},{"id":"https://openalex.org/keywords/solid-tumor-immunotherapy","display_name":"solid tumor immunotherapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7950999736785889},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.7574999928474426},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6517000198364258},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.48649999499320984},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44279998540878296},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.439300000667572},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.39419999718666077},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.37229999899864197},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3458999991416931},{"id":"https://openalex.org/C3020653616","wikidata":"https://www.wikidata.org/wiki/Q189146","display_name":"Cell mediated immunity","level":4,"score":0.30230000615119934},{"id":"https://openalex.org/C3018558359","wikidata":"https://www.wikidata.org/wiki/Q1660157","display_name":"Immune escape","level":3,"score":0.29280000925064087}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0317","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A359.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0317","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0317","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A359.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225155113.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225174458","https://openalex.org/W2964164662","https://openalex.org/W4379647379","https://openalex.org/W2209972269","https://openalex.org/W4376112427","https://openalex.org/W3162282958","https://openalex.org/W4294931083","https://openalex.org/W2575882253","https://openalex.org/W7225167502","https://openalex.org/W7225195354"],"abstract_inverted_index":{"Background":[0],"Unconventional":[1],"T":[2,9,15,114,188,292],"cells,":[3,10,13,16,19],"also":[4],"referred":[5],"to":[6,45,63,177,194,225],"as":[7,196],"innatelike":[8],"including":[11],"iNKT":[12],"\u03b3\u03b4":[14],"and":[17,27,42,103,123,149,154,220,260,269,273,327],"MAIT":[18,67,89,167,239,305,314],"play":[20],"a":[21,107,173,197,236,246,317],"critical":[22],"role":[23],"in":[24,125,192,210,235],"bridging":[25],"innate":[26],"adaptive":[28],"immunity.":[29],"These":[30,307],"cell":[31,263],"types":[32],"possess":[33],"intrinsic":[34],"tumorhoming":[35],"capacity,":[36],"strong":[37],"infiltration":[38],"into":[39],"solid":[40,57],"tumors,":[41],"the":[43,47,126,165,200,204,231,323],"ability":[44],"reshape":[46],"tumor":[48,58,215],"microenvironment":[49],"(TME),":[50],"making":[51],"them":[52],"highly":[53,303],"attractive":[54],"modalities":[55],"for":[56,95,322],"immunotherapy.":[59],"They":[60],"respond":[61],"rapidly":[62],"diverse":[64],"stimuli,":[65],"with":[66,133,145,213,249],"cells":[68,81,90,116,168,189,206,315],"uniquely":[69],"recognizing":[70],"microbederived":[71],"vitamin":[72],"B":[73],"metabolites":[74],"presented":[75],"by":[76],"MR1.":[77],"Importantly,":[78],"because":[79],"these":[80],"do":[82],"not":[83],"induce":[84],"graftversushost":[85],"disease":[86],"(GvHD),":[87],"CARengineered":[88,313],"are":[91],"particularly":[92],"well":[93],"suited":[94],"allogeneic,":[96,319],"offtheshelf":[97,320],"therapeutic":[98,228],"applications":[99],"across":[100],"both":[101],"cancer":[102],"autoimmune":[104],"diseases.Methods":[105],"Using":[106],"novel":[108],"feeder-free":[109],"proprietary":[110],"method,":[111],"Mucosal-Associated":[112],"Invariant":[113],"(MAIT)":[115],"were":[117,140,169,190,207,223],"isolated":[118],"from":[119],"human":[120,147],"peripheral":[121],"bloods":[122],"stimulated":[124],"G-Rex":[127],"6-well":[128],"plates":[129],"via":[130,159],"MR1-restricted":[131],"stimulation":[132],"5-amino-6-(D-ribitylamino)":[134],"uracil":[135],"(5-A-RU).":[136],"The":[137,257],"expanding":[138],"cultures":[139,240],"maintained":[141],"over":[142,250],"14":[143],"days":[144],"recombinant":[146],"IL-7":[148],"IL-15.":[150],"Cell":[151],"fold-expansion,":[152],"viability,":[153],"immunophenotypic":[155],"purity":[156,252],"longitudinally":[157],"monitored":[158],"flow":[160],"cytometry.":[161],"Following":[162,230],"robust":[163],"expansion,":[164],"activated":[166],"genetically":[170],"engineered":[171,191],"using":[172],"modified":[174],"lentiviral":[175],"vector":[176],"express":[178],"either":[179],"anti-CD19":[180],"or":[181],"anti-GPC3":[182],"CAR":[183,267],"constructs;":[184],"conventional":[185,288],"CD8":[186,290],"+":[187,291],"parallel":[193],"serve":[195],"control.":[198],"Finally,":[199],"functional":[201],"profiles":[202],"of":[203,286,302,325],"CAR-MAIT":[205],"characterized":[208],"through":[209],"vitro":[211],"co-culture":[212],"corresponding":[214,287],"targets,":[216,277],"where":[217],"antigen-specific":[218],"cytotoxicity":[219,272],"IFN\u03b3":[221],"secretion":[222],"assessed":[224],"evaluate":[226],"their":[227,279,331],"potency.Results":[229],"optimized":[232],"expansion":[233,248,295],"protocol":[234],"small":[237],"scale,":[238],"within":[241],"2":[242],"weeks":[243],"currently":[244],"achieved":[245],">600-fold":[247],"95%":[251],"based":[253],"on":[254],"V\u03b17.2":[255],"staining.":[256],"expanded":[258],"CD19":[259],"GPC3":[261],"CARMAIT":[262],"populations":[264],"exhibited":[265],"high":[266],"expression":[268],"demonstrated":[270],"antigenspecific":[271],"inhibition":[274],"against":[275],"malignant":[276],"although":[278],"activity":[280],"was":[281],"comparatively":[282],"lesser":[283],"than":[284],"that":[285,311],"CARexpressing":[289],"cells.Conclusions":[293],"Our":[294],"strategy":[296],"reliably":[297],"generates":[298],"clinically":[299],"relevant":[300],"quantities":[301],"pure":[304],"cells.":[306],"preclinical":[308],"findings":[309],"demonstrate":[310],"scalable,":[312],"represent":[316],"promising":[318],"platform":[321],"treatment":[324],"cancers":[326],"immunemediated":[328],"diseases,":[329],"supporting":[330],"continued":[332],"advancement":[333],"toward":[334],"clinical":[335],"development.":[336]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}